Clinical Trials and Data Science Conference

Daniel Millar, MBA

Senior Director, Strategic Business Transformation

Deliverables from IMI EU-PEARL and How these will be Sustained Post-Project

Cecile Spiertz, MSC

Netherlands

Protocol Development for Master Protocol Studies – Balancing Structure with Function

Jonathan Mackinnon, PHD

Parexel International, Spain

Associate Director, Medical Writing Services

Acceptance of Design and Data of Complex Innovative Design Trials by Key Decision-Makers

Christine Fletcher, MSC

GlaxoSmithKline, United Kingdom

VP/Head, Speciality and Primary Care Statistics

Panel discussion with Q&A

Olga Kholmanskikh Van Criekingen, MD, PHD

Federal Agency for Medicines and Health Products, Belgium

Clinical assessor